InVivoMAb anti-human CD28

DNA scaffolds enable efficient and tunable functionalization of biomaterials for immune cell modulation. Huang X et al., 2021 Feb, Nat Nanotechnol

MDSC subtypes and CD39 expression on CD8(+) T cells predict the efficacy of anti-PD-1 immunotherapy in patients with advanced NSCLC. Koh J et al., 2020 Nov, Eur J Immunol

Glycogen synthase kinase-3 controls IL-10 expression in CD4(+) effector T-cell subsets through epigenetic modification of the IL-10 promoter. Hill EV et al., 2015 Apr, Eur J Immunol

Profiling T cell activation using single-molecule fluorescence in situ hybridization and flow cytometry. Bushkin Y et al., 2015 Jan 15, J Immunol

Ligation of CD28 by its natural ligand CD86 in the absence of TCR stimulation induces lipid raft polarization in human CD4 T cells. Kovacs B et al., 2005 Dec 15, J Immunol